Business
NeoGenomics Announces Three-Year Contract to be Cornerstone Oncology and Cancer Testing Laboratory for Large, National Group Purchasing Organization
FT. MYERS, FL / ACCESSWIRE / March 2, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, announced today
About this update from Neogenomics, Inc.
[{"type":"text","content":"FT. MYERS, FL / ACCESSWIRE / March 2, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, announced today that the company has been awarded a three-year contract with HealthTrust Purchasing Group (HPG). Effective March 1, 2020, NeoGenomics will serve as the cornerstone laboratory for HPG's Specialized Reference Laboratory for Oncology & Cancer Genetics, a newly-created category for oncology diagnostics in personalized medicine.\"We are honored to be awarded this contract to provide our testing services for all HPG-affiliated hospitals, cancer centers, pathology groups, and oncology/physician providers nationwide,\" said Douglas M. VanOort, Chairman and CEO, NeoGenomics. \"This agreement gives NeoGenomics the distinction of being the first specialized oncology laboratory to become a preferred in-network lab option to help HPG members diagnose and treat cancer.\"The agreement secures standardized corporate pricing for all HPG-affiliated facilities and health care providers nationwide, and it provides access to the extensive portfolio of NeoGenomics' cancer diagnostic and oncology genetics testing services and emerging informatics solutions.About NeoGenomics, Inc.NeoGenomics, Inc. specializes in cancer genetics testing and information services. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company's Pharma Services Division serves pharmaceutical clients in clinical trials and drug development.Headquartered in Fort Myers, FL, NeoGenomics operates CAP accredited and CLIA certified laboratories in Ft. Myers and Tampa, Florida; Aliso Viejo, Carlsbad, Fresno and San Diego California; Houston, Texas; Atlanta, Georgia; Nashville, Tennessee; and CAP accredited laboratories in Rolle, Switzerland, and Singapore. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and pharmaceutical firms in Europe and Asia. For additional information about NeoGenomics, visit http://www.neogenomics.com/.About HealthTrustHealthTrust (HealthTrust Purchasing Group, L.P.) is committed to strengthening provider performance and clinical excellence t...